What Is Endometriosis and Why Does It Take So Long to Diagnose?

What Is Endometriosis?

Endometriosis is a chronic, systemic inflammatory condition in which tissue similar to the endometrium (the lining of the uterus) grows outside the uterus. These lesions — commonly found on the ovaries, fallopian tubes, peritoneum, bowel, bladder, and in rare cases distant organs such as the lungs or diaphragm — respond to the hormonal fluctuations of the menstrual cycle. They proliferate under estrogen stimulation and bleed during menstruation, but unlike the uterine lining, this blood has no way to leave the body, triggering inflammation, scar tissue (adhesions), and cysts called endometriomas (or chocolate cysts when on the ovaries).

Endometriosis affects an estimated 190 million people worldwide — approximately 10% of those with a uterus during their reproductive years. Despite its prevalence, it remains profoundly underdiagnosed and undertreated. The condition is staged from I (minimal) to IV (severe) based on the location, extent, and depth of lesions, as well as the severity of adhesions. Critically, disease stage correlates poorly with symptom severity — someone with Stage I endometriosis may experience debilitating pain while someone with Stage IV may have minimal symptoms.

Symptoms of Endometriosis

The hallmark symptom of endometriosis is dysmenorrhea — menstrual pain that is disproportionately severe and frequently disabling. Many affected individuals describe menstrual pain so intense that it causes vomiting, fainting, or inability to attend school or work. However, endometriosis pain extends well beyond menstruation and includes:

• Chronic pelvic pain: Persistent pain in the lower abdomen, pelvis, or lower back that is not exclusively cyclic.
• Dyspareunia: Pain during or after sexual intercourse, particularly deep penetration, due to lesions on the uterosacral ligaments or rectovaginal space.
• Dyschezia: Painful bowel movements, particularly around menstruation.
• Dysuria: Painful urination, which may be cyclic and associated with bladder endometriosis.
• Fatigue: Profound, often debilitating fatigue that is frequently underrecognized as an endometriosis symptom.
• Infertility: Endometriosis is found in 30-50% of people with infertility; mechanisms include distorted pelvic anatomy, impaired implantation, and altered immune environment.

Gastrointestinal symptoms — bloating, diarrhea, constipation, and nausea — are especially common with bowel endometriosis and frequently lead to misdiagnosis as irritable bowel syndrome (IBS).

Why Diagnosis Takes So Long

The average time from symptom onset to diagnosis is 7 to 10 years across Western countries, a delay that represents one of the most significant failures in reproductive health care. Multiple systemic factors contribute to this gap. First, symptom normalization is pervasive: patients are repeatedly told that severe menstrual pain is normal, that they are exaggerating, or that it will improve with age. Many people internalize these dismissals and stop seeking care.

Second, no reliable non-invasive diagnostic test exists. Blood tests, pelvic exams, and even MRI or transvaginal ultrasound can suggest endometriosis (particularly ovarian endometriomas) but cannot definitively detect all lesion types or locations. The gold standard for diagnosis remains laparoscopic surgery with biopsy of suspected lesions — an invasive procedure that many clinicians are reluctant to recommend and many healthcare systems are slow to provide. The diagnostic path from primary care to specialist and then to surgery can take years, particularly in systems with long wait times.

Medical Biases and the Pain Gap

Research consistently documents a gender pain gap in medicine: studies show that women and people assigned female at birth are less likely to receive adequate pain treatment, more likely to have their pain attributed to psychological causes, and more likely to experience longer waits before being prescribed analgesics. Endometriosis is a particularly stark example of this disparity — it is a condition almost exclusively affecting people with uteruses, its primary symptom is pain, and it has historically received minimal research funding relative to its prevalence and impact.

Racial disparities compound these challenges. Studies have shown that Black patients with endometriosis are significantly less likely to receive a diagnosis than white patients, despite similar or higher disease prevalence — reflecting broader patterns of racial bias in medical care. The combination of symptom normalization, diagnostic limitations, and systemic biases creates a perfect storm of delay that exposes affected individuals to years of unnecessary suffering and damage from progressive disease.

Diagnosing Endometriosis Today

A thorough clinical evaluation begins with a detailed history of symptoms, their relationship to the menstrual cycle, and their impact on quality of life. A pelvic examination may reveal nodularity along the uterosacral ligaments, fixed uterine position (indicative of adhesions), or adnexal tenderness. Transvaginal ultrasound (TVUS) performed by a skilled operator can detect ovarian endometriomas and some deep infiltrating endometriosis lesions, but is less reliable for peritoneal disease.

MRI with dedicated bowel preparation is increasingly used to map deep infiltrating endometriosis prior to surgical planning, particularly when bowel or bladder involvement is suspected. Ultimately, definitive diagnosis requires diagnostic laparoscopy — a minimally invasive surgical procedure in which a camera is inserted into the abdomen to visualize and biopsy lesions. Many specialists now recommend presumptive treatment based on clinical presentation in suspected cases, without waiting for surgical confirmation, to reduce unnecessary delay.

Treatment Approaches

There is no cure for endometriosis, but treatment can effectively suppress symptoms, slow disease progression, and improve quality of life. The approach is individualized based on symptom severity, desire for fertility, age, and prior treatment history.

Hormonal therapies aim to reduce estrogen stimulation of endometriotic lesions and suppress menstruation. Combined oral contraceptives, progestins (norethindrone acetate, dienogest), and the levonorgestrel IUD can effectively control pain for many patients. GnRH agonists and antagonists (such as elagolix/Orilissa or leuprolide/Lupron) create a temporary medical menopause and can dramatically reduce pain, but side effects including bone loss and vasomotor symptoms limit long-term use. Hormonal therapies do not eliminate existing lesions but suppress their activity.

Excision surgery — laparoscopic removal of endometriotic lesions — is the most effective treatment for symptom relief and is associated with better outcomes than ablation (burning lesions). Surgery performed by a skilled endometriosis excision specialist at a high-volume center significantly improves outcomes. For people seeking fertility, surgery to restore normal pelvic anatomy can improve natural conception rates, though assisted reproduction (IVF) is often recommended in parallel. Multidisciplinary care incorporating pain management, pelvic floor physical therapy, and psychological support is increasingly recognized as essential for comprehensive endometriosis care.